- Home
- RVSB vs GNLX Comparison
RVSB vs GNLX Comparison
Compare RVSB & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVSB
- GNLX
- Stock Information
- Founded
- RVSB 1923
- GNLX 2001
- Country
- RVSB United States
- GNLX United States
- Employees
- RVSB N/A
- GNLX N/A
- Industry
- RVSB Savings Institutions
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- RVSB Finance
- GNLX Health Care
- Exchange
- RVSB Nasdaq
- GNLX Nasdaq
- Market Cap
- RVSB 107.6M
- GNLX 128.0M
- IPO Year
- RVSB 1993
- GNLX 2023
- Fundamental
- Price
- RVSB $5.28
- GNLX $4.70
- Analyst Decision
- RVSB Buy
- GNLX Strong Buy
- Analyst Count
- RVSB 1
- GNLX 4
- Target Price
- RVSB $7.00
- GNLX $17.75
- AVG Volume (30 Days)
- RVSB 78.3K
- GNLX 133.8K
- Earning Date
- RVSB 10-23-2025
- GNLX 11-13-2025
- Dividend Yield
- RVSB 1.52%
- GNLX N/A
- EPS Growth
- RVSB 163.90
- GNLX N/A
- EPS
- RVSB 0.24
- GNLX N/A
- Revenue
- RVSB $51,318,000.00
- GNLX N/A
- Revenue This Year
- RVSB $11.67
- GNLX N/A
- Revenue Next Year
- RVSB $12.55
- GNLX N/A
- P/E Ratio
- RVSB $21.96
- GNLX N/A
- Revenue Growth
- RVSB 9.48
- GNLX N/A
- 52 Week Low
- RVSB $4.45
- GNLX $1.99
- 52 Week High
- RVSB $6.59
- GNLX $5.89
- Technical
- Relative Strength Index (RSI)
- RVSB 56.96
- GNLX 70.91
- Support Level
- RVSB $5.17
- GNLX $4.17
- Resistance Level
- RVSB $5.44
- GNLX $4.45
- Average True Range (ATR)
- RVSB 0.12
- GNLX 0.28
- MACD
- RVSB 0.01
- GNLX 0.03
- Stochastic Oscillator
- RVSB 60.53
- GNLX 87.00
About RVSB Riverview Bancorp Inc
Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.